2021-01-11,NuCana (NCNA) Looks Good: Stock Adds 5.7% in Session
2020-12-21,NuCana Appoints Andrew Kay as Board Chairman
2020-12-07,Is NCNA A Good Stock To Buy Now?
2020-12-01,"The Daily Biotech Pulse: Pfizer, BioNTech File Marketing Application In Europe, NuCana Jumps On Data, Amarin Takes On Hikma In Patent Lawsuit"
2020-11-30,Final Data from the Phase Ib Study of Acelarin plus Cisplatin in Patients with Advanced Biliary Tract Cancer Published Online Ahead of Print in The Oncologist
2020-11-19,NuCana Reports Third Quarter 2020 Financial Results and Provides Business Update
2020-11-17,NuCana to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
2020-11-12,NuCana to Present at the Jefferies Virtual London Healthcare Conference
2020-11-10,Why NuCana (NCNA) Might Surprise This Earnings Season
2020-11-03,Companies Like NuCana (NASDAQ:NCNA) Are In A Position To Invest In Growth
2020-10-13,NuCana Expands its Board of Directors with the Appointment of Bali Muralidhar
2020-10-02,"Metacrine, Prelude Therapeutics See Activist Action"
2020-09-24,NuCana (NCNA) Surges: Stock Moves 6.3% Higher
2020-09-21,NuCana Presents Three Posters at the ESMO Virtual Congress 2020
2020-09-21,NuCana Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriters Option to Purchase Additional American Depositary Shares
2020-09-17,NuCana Announces Pricing of a Public Offering of American Depositary Shares
2020-09-16,NuCana Announces Proposed Public Offering of American Depositary Shares
2020-08-19,NuCana Reports Second Quarter 2020 Financial Results and Provides Business Update
2020-08-18,Should You Buy NuCana (NCNA) Ahead of Earnings?
2020-08-05,What Kind Of Shareholders Hold The Majority In NuCana plc's (NASDAQ:NCNA) Shares?
2020-07-31,Oppenheimer: These 3 Strong Buy Stocks Have Over 50% Upside Potential
2020-07-24,"Benzinga's Top Upgrades, Downgrades For July 24, 2020"
2020-07-02,Blueprint Medicines Files NDA to FDA for Pralsetinib in MTC
2020-06-29,Axsome's AXS-05 Gets Breakthrough Therapy Tag for AD Agitation
2020-06-24,Gilead to Buy 49.9% Stake in Private Biotech for $275M
2020-06-18,Protagonist Therapeutics' PTG-300 Gets FDA's Orphan Drug Tag
2020-06-16,ACADIA Files sNDA for Nuplazid in Dementia-Related Psychosis
2020-06-10,Immunic Gets FDA Allowance for Phase II Coronavirus Study
2020-06-02,Why NuCana (NCNA) Stock Might be a Great Pick
2020-06-01,Will NuCana Continue to Surge Higher?
2020-05-28,Top Ranked Momentum Stocks to Buy for May 28th
2020-05-27,5 Health Care Stocks to Bet on as Coronavirus Woes Linger
2020-05-27,NuCana to Present at the 2020 Jefferies Virtual Healthcare Conference
2020-05-24,3 Strong Buy Healthcare Stocks That Could Double in the Next Year
2020-05-19,NuCana Reports First Quarter 2020 Financial Results and Provides Business Update
2020-05-18,NuCana Announces the Re-Opening of Enrollment in Multiple Clinical Studies After Temporary Pause Due to COVID-19 Pandemic
2020-05-15,NuCana to Present Two Abstracts at the American Association for Cancer Research (AACR) Annual Meeting 2020
2020-05-05,NuCana Announces Re-Opening of Global Phase III Study of Acelarin Plus Cisplatin in Patients with Biliary Tract Cancer (NuTide:121)
2020-04-02,NuCana Provides Update on Impact of COVID-19 on Clinical Studies
2020-03-18,NuCana (NASDAQ:NCNA) Is In A Good Position To Deliver On Growth Plans
2020-03-11,"The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment"
2020-03-10,NuCana Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Business Update
2020-03-10,NuCana Reports Preliminary Data from Phase II Study of Single-Agent Acelarin (NUC-1031) in Patients with Platinum-Resistant Ovarian Cancer
2020-03-04,NuCana Receives Positive Opinion for Orphan Drug Designation in the European Union for Acelarin (NUC-1031) for the Treatment of Patients with Biliary Tract Cancer
2020-02-29,"Harvard Sold Facebook, Palo Alto Stock. Heres What It Bought."
2020-02-25,NuCana (NCNA) to Report Q4 Earnings: What's in the Cards?
2020-02-25,NuCana to Present at the Cowen and Company 40th Annual Health Care Conference
2020-01-27,NuCana Announces First Patients Dosed in Both US and Europe in Phase III Study of Acelarin (NUC-1031) for the First-Line Treatment of Patients with Biliary Tract Cancer
2020-01-03,Innate Pharma's Filing for Leukemia Drug Accepted in Europe
2019-12-20,NuCana plc (NCNA): Are Hedge Funds Right About This Stock?
2019-12-11,New Strong Buy Stocks for December 11th
2019-11-27,"Sorrento Turns Down Two All-Cash Takeover Bids, Stock Jumps"
2019-11-26,NuCana to Participate in the Piper Jaffray 31st Annual Healthcare Conference
2019-11-22,3 Strong Buy Stocks Set for Triple Digit Gains
2019-11-20,Achillion's (ACHN) Danicopan Gets EMA's PRIME Tag for PNH
2019-11-14,NuCana to Present at the Jefferies 2019 London Healthcare Conference
2019-11-13,NuCana Reports Third Quarter 2019 Financial Results and Provides Business Update
2019-10-29,NuCana Presents Data at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
2019-10-25,NuCana Announces FDA Clearance to Commence Phase III Study of Acelarin (NUC-1031) for the First-Line Treatment of Patients with Biliary Tract Cancer
2019-10-17,Lilly's Pancreatic Cancer Candidate Fails in Phase III Study
2019-10-16,Novavax Begins Phase III Study on Influenza Vaccine Candidate
2019-09-20,What Percentage Of NuCana plc (NASDAQ:NCNA) Shares Do Insiders Own?
2019-09-17,Seattle Genetics' Enfortumab Vedotin BLA Gets Priority Review
2019-09-16,Amgen's Kyprolis Combo Improves PFS in Multiple Myeloma Study
2019-09-10,FDA Grants Orphan Drug Status to Acceleron's PAH Candidate
2019-09-06,"NuCana plc (NCNA) Shares March Higher, Can It Continue?"
2019-09-03,Acorda (ACOR) Down More Than 60% in 3 Months: Here's Why
2019-09-02,Akari's Nomacopan Gets Orphan Drug Tag for Rare Disease
2019-08-29,NuCana to Present at the Morgan Stanley 17th Annual Global Healthcare Conference
2019-08-27,NuCana to Participate in Citis 14th Annual Biotech Conference
2019-08-21,NuCana Reports Second Quarter 2019 Financial Results and Provides Business Update
2019-08-21,NuCana Stops Patient Enrollment in Pancreatic Cancer Study
2019-08-20,NuCana stock falls 21% after company suspends patient enrollment in pancreatic cancer trial
2019-08-20,Enrollment in the Independent Investigator-Sponsored Phase III Metastatic Pancreatic Study ACELARATE Has Been Suspended Following a Prespecified Futility Analysis
2019-08-18,Analysts Recommend These 2 Falling Knives
2019-07-18,NuCana Initiates Dosing in Phase I Study for Solid Tumors
2019-07-17,NuCana Announces First Patients Dosed in Phase I Study of NUC-7738
2019-06-13,NuCana's Biliary Tract Cancer Candidate Gets Orphan Drug Tag
2019-06-13,"The Daily Biotech Pulse: Savara Slumps On Flunked Trial, NuCana Takes Off, Tetraphase Downsizes"
2019-06-12,NuCana Receives Orphan Drug Designation from the U.S. Food and Drug Administration for Acelarin® for the Treatment of Biliary Tract Cancer
2019-05-30,NuCana to Present at the Jefferies 2019 Healthcare Conference
2019-05-14,NuCana Reports First Quarter 2019 Financial Results and Provides Business Update
2019-04-02,NuCana to Participate in the William Blair 3rd Late-Stage Therapeutics Conference
2019-03-30,"Introducing NuCana (NASDAQ:NCNA), The Stock That Dropped 10% In The Last Year"
2019-03-18,Will NuCana Continue to Surge Higher?
2019-03-07,NuCana Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Business Update
2019-03-05,NuCana to Present at the Cowen and Company 39th Annual Health Care Conference
2019-02-27,NuCana to Present at the American Association for Cancer Research (AACR) Annual Meeting 2019
2019-01-25,"NuCana's stock soars after withdrawing ADS offering, which triggered a big selloff"
2019-01-25,NuCana plc Announces Withdrawal of Public Offering of ADSs
2019-01-23,NuCana plc Announces Proposed Public Offering of ADSs
2019-01-07,"Amarin Down on Lower '19 View, Posts Preliminary '18 Results"
2018-11-28,NuCana to Participate in Citi's 2018 Global Healthcare Conference
2018-11-27,NuCana Reports Third Quarter 2018 Financial Results and Provides Business Update
2018-11-20,NuCana to Participate in the 2018 Evercore ISI HealthCONx Conference
2018-11-07,NuCana to Participate in the Jefferies 2018 London Healthcare Conference
2018-11-01,NuCana Announces First Patients Enrolled in Phase Ib Study of NUC-3373 in Advanced Colorectal Cancer
2018-10-24,NuCana Sees Hammer Chart Pattern: Time to Buy?
2018-10-22,NuCana Presents Data from Phase I Study of NUC-3373 at ESMO 2018
2018-10-21,NuCana Reports Additional Promising Clinical Data on NUC-1031 (Acelarin®) as Front-Line Treatment of Advanced Biliary Tract Cancer at ESMO 2018
